2/2024
ILLUMINA FAILS TO REVIVE 2 DNA PATENTS ON APPEAL
European patent officials have revoked two of Illumina Cambridge Ltd.’s patents for DNA-sequencing techniques, ruling that the patented claims went beyond the original application, in the latest setback for the biotech giant.
